When does the Rubicon Research Limited IPO open and close?

The Rubicon Research Limited IPO opens for subscription on October 9, 2025 and closes on October 13, 2025. Shares are expected to list on October 16, 2025.

What is the issue price of the Rubicon Research Limited IPO?

The Rubicon Research Limited IPO was priced at ₹485 per equity share.

What is the lot size for the Rubicon Research Limited IPO?

The lot size is 30 equity shares. At ₹485 per share, one lot requires ₹14,550.

What is the issue size of the Rubicon Research Limited IPO?

The total issue size is ₹1,377.50 crore. This comprises a fresh issue of ₹500.00 crore, which the company receives, and an offer for sale of ₹877.50 crore, which goes to selling shareholders.

How did Rubicon Research Limited perform on listing?

Rubicon Research Limited opened at ₹620 against an issue price of ₹485, a premium of 27.84% on debut.

Who are the lead managers for the Rubicon Research Limited IPO?

The book running lead managers are Axis Capital Limited. The registrar to the issue is MUFG Intime India Private Limited.

Listed on ExchangeMAINBOARDRUBICON Official SEBI Filing

Rubicon Research Limited

Issue Price

₹485

Total Issue Size

₹1,377.5 Cr

Listing Date

16 Oct – 16 Oct 2025

Market Lot

30 Shares

Listing Price

₹620

Listing Debut

+27.84%

Issue Timeline & Lifecycle

RHP Filed

7 Oct 2025

Issue Opens

9 Oct 2025

Issue Closes

13 Oct 2025

Allotment

14 Oct 2025

Indicative, per filing

Exchange Debut

16 Oct 2025

RHP Filed

7 Oct 2025

Issue Opens

9 Oct 2025

Issue Closes

13 Oct 2025

Allotment

14 Oct 2025 · indicative

Exchange Debut

16 Oct 2025

Subscription Demand

Day 3 Closed

Updated:13 Oct, 7:00 pm·NSE

103.90x Fully Subscribed

170.97 Cr shares bid on 1.65 Cr total issue

Momentum

Day 3103.90xLatest

Qualified Institutional (QIB)

130.26x50% Quota

Non-Institutional / HNI

97.61x15% Quota

Retail Individual (RII)

35.47x35% Quota

Employee Reservation

16.80xReserved

Qualified Institutional (QIB)50% Quota

130.26x

Non-Institutional / HNI15% Quota

97.61x

Retail Individual (RII)35% Quota

35.47x

Employee ReservationReserved

16.80x

Fundamentals & Key Metrics

Period:ASOF20250630· Multiples Annualised

Valuation & Multiples

4 items

Implied Market Capℹ

₹7,990 Cr

P/E Ratioℹ

43.15x

P/B Ratioℹ

12.62x

Price to Salesℹ

5.67x

Profitability & Returns

5 items

EBITDA Marginℹ

22.62%

Profit Marginℹ

12.28%

RoNWℹ

7.29%

Basic EPSℹ

₹2.81

Book Valueℹ

₹38.44

Financial Health & Solvency

1 item

Net Worthℹ

₹593.67 Cr

Financials at a glance

Restated Consolidated

Statement: Income StatementPeriod: Restated Multi-Year (FY)

Shareholding, Ownership & Dilution

9 disclosed holders

Pre-Offer Shareholding Distribution

Breakdown of major disclosed shareholders prior to the issue

100.00% Pre-Issue

100%Pre-Offer

General Atlantic Singapore RR Pte. Ltd.

49.90%

Shivanand Mankekar HUF

14.42%

Surabhi Parag Sancheti

8.45%

Sumant Sudhir Pilgaonkar

8.43%

Sudhir Dhirendra Pilgaonkar

4.15%

Others

14.65%

Ownership Impact of the IPO

What is newly issued, what changes hands, and what stays put

100.00% Post-Issue

100%POST-OFFER

Pre-IPO Retained

82.76%

Fresh-Issue Dilution₹500 Cr · 36.3% of offer

6.26%

OFS Changes Hands₹877.5 Cr · 63.7% of offer

10.98%

Total Company Offered in IPO17.24%

Calculated from share counts disclosed in the offer filing.

Disclosed Pre-Offer Shareholders Table

AI Summary

Filing-backed

Prospectus Research

Analyze business model, competitive strengths, use of issue proceeds, and disclosed risk factors with official page citations.

Issue intermediaries

Lead book managers

Axis Capital Limited

Registrar to the issue

MUFG Intime India Private Limited

Listing venues

NSE,BSE

Listed Peer Valuation & Returns

Industry Avg P/E:24.10x

Swipe left / right to view all valuation metrics→

Company
Rubicon Research LimitedThis Issue	₹485	55.88x	₹1.28K Cr	₹8.68	₹35.53	29.02%
Dr. Reddy’s Laboratories Limited	₹1,223.7	18.05x	₹32.64K Cr	₹67.79	₹402.78	18.53%
Aurobindo Pharma Limited	₹1,083.85	18.12x	₹31.72K Cr	₹59.81	₹560.22	11.15%
Strides Pharma Science Limited	₹824.75	18.72x	₹4.57K Cr	₹44.05	₹277.34	17.51%
Zydus Lifesciences Limited	₹981.7	21.83x	₹23.24K Cr	₹44.97	₹238.05	21.34%
Lupin Limited	₹1,910.15	26.64x	₹22.71K Cr	₹71.69	₹377.18	21.00%
Alembic Pharmaceuticals Limited	₹900.2	30.33x	₹6.67K Cr	₹29.68	₹264.09	11.63%
Sun Pharmaceutical Industries Limited	₹1,594.95	34.98x	₹52.58K Cr	₹45.60	₹300.99	16.16%